two cross-over studies were carried out in 23 patients with type 2 diabetes , to examine whether glipizide , a potent sulphonylurea with fast and complete absorption and rapid elimination ( t1/2 less than 5 h ) , can be given once-daily without loss of therapeutic effect .
C0011860
type 2 diabetes
C0017642
glipizide